These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11108820)

  • 1. Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine.
    Sandoval V; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2000 Dec; 409(3):265-71. PubMed ID: 11108820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia.
    Haughey HM; Fleckenstein AE; Metzger RR; Hanson GR
    J Neurochem; 2000 Oct; 75(4):1608-17. PubMed ID: 10987842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.
    Metzger RR; Haughey HM; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1077-85. PubMed ID: 11082443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid and reversible change in dopamine transporters induced by methamphetamine.
    Fleckenstein AE; Metzger RR; Gibb JW; Hanson GR
    Eur J Pharmacol; 1997 Apr; 323(2-3):R9-10. PubMed ID: 9128855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters.
    Kokoshka JM; Vaughan RA; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 1998 Nov; 361(2-3):269-75. PubMed ID: 9865517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
    Sandoval V; Riddle EL; Ugarte YV; Hanson GR; Fleckenstein AE
    J Neurosci; 2001 Feb; 21(4):1413-9. PubMed ID: 11160413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptors.
    Ugarte YV; Rau KS; Riddle EL; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 2003 Jul; 472(3):165-71. PubMed ID: 12871750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine rapidly decreases vesicular dopamine uptake.
    Brown JM; Hanson GR; Fleckenstein AE
    J Neurochem; 2000 May; 74(5):2221-3. PubMed ID: 10800970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal by [D-Ala2,D-Leu5]enkephalin of the dopamine transporter loss caused by methamphetamine.
    Tsao LI; Cadet JL; Su TP
    Eur J Pharmacol; 1999 May; 372(3):R5-7. PubMed ID: 10395030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.
    Frey K; Kilbourn M; Robinson T
    Eur J Pharmacol; 1997 Sep; 334(2-3):273-9. PubMed ID: 9369358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity.
    Fricks-Gleason AN; German CL; Hoonakker AJ; Friend DM; Ganesh KK; Carver AS; Hanson GR; Fleckenstein AE; Keefe KA
    Synapse; 2016 Apr; 70(4):139-46. PubMed ID: 26799527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and reversible effects of methamphetamine on dopamine transporters.
    Fleckenstein AE; Metzger RR; Wilkins DG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1997 Aug; 282(2):834-8. PubMed ID: 9262348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users.
    Wilson JM; Kalasinsky KS; Levey AI; Bergeron C; Reiber G; Anthony RM; Schmunk GA; Shannak K; Haycock JW; Kish SJ
    Nat Med; 1996 Jun; 2(6):699-703. PubMed ID: 8640565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.
    Willett MC; Dluzen DE
    Brain Res; 2004 Dec; 1029(2):186-94. PubMed ID: 15542073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum.
    Eyerman DJ; Yamamoto BK
    J Pharmacol Exp Ther; 2005 Jan; 312(1):160-9. PubMed ID: 15331654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain.
    Kokoshka JM; Metzger RR; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    Brain Res; 1998 Jul; 799(1):78-83. PubMed ID: 9666084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism.
    Baucum AJ; Rau KS; Riddle EL; Hanson GR; Fleckenstein AE
    J Neurosci; 2004 Mar; 24(13):3436-43. PubMed ID: 15056723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Melega WP; Lacan G; Desalles AA; Phelps ME
    Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.